Progression free survival (PFS) analysis revealed that both PLOD1 and PLOD3 were linked to poor prognosis in HNSCC (both p < 0.01), while there was no significant association between PFS and PLOD2 (Fig. 2C, p = 0.087). The gene discussed is PLOD2; the disease is head and neck squamous cell carcinoma.